NovaBay Pharma (NBY) Reports Q3 Loss of $0.08/sh
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
OCCI, PMCB, BRID, More
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
OCCI, PMCB, BRID, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.08), versus ($0.02) reported last year. Revenue for the quarter came in at $2.2 million, versus $1.62 million reported last year.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler sees Google TPU sales hitting $104BN by 2028
- Arm Holdings falls as CFO stock sale weighs on sentiment
- BRC Group to acquire Sangoma Technologies for ~$204M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
